Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Bolt Biotherapeutics ( (BOLT) ) has shared an announcement.
Dr. Mahendra Shah resigned from Bolt Biotherapeutics’ Board of Directors, effective December 31, 2024, for personal reasons. Following his resignation, Dr. Jakob Dupont was appointed to the Audit Committee and the Nominating and Corporate Governance Committee, ensuring continuity in the company’s governance.
More about Bolt Biotherapeutics
YTD Price Performance: -55.36%
Average Trading Volume: 149,035
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $19.14M
See more insights into BOLT stock on TipRanks’ Stock Analysis page.
